Louis Wehenkel

Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium.

Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege.

KitoZyme SA manufactures biopolymers and provides medical device products. It develops and produces chitosan (and derivatives), chitin-glucan and beta-glucan, exclusively extracted from renewable, non-GMO vegetable sources. The firm specializes in weight management, digestive health and cardiovascular health products. The company was founded in December 2000 and is headquartered in Herstal, Belgium.

HORPI Systems SA develops, produces and commercializes biocontrol systems for pests. The firm offers ladybirds that are used for biological control of scale insects and aphids. The company was founded in 1999 and is headquartered in Vise, Belgium.

Entraide Protestante is based in Dour, Belgium and is known for providing accommodation for the elderly and early childhood education through their "Garden of Eden" crèche. The Belgian company's Château de Fonteny residence services allow the elderly to live independently in a pleasant setting nearby. Entraide Protestante is a non-profit organization founded in 1950.

Diagenode SA provides solutions for epigenetics research, biological sample preparation, and diagnostics assays. It offers Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company was founded in 2003 and is headquartered in Seraing, Belgium.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium.

Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium.

THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations.

Sagitta Biotech SA provides research and development of biotechnology. The company is based in Liege, Belgium. The Belgian company was founded in 2019. Benjamin Damien has been the CEO of the company since 2019.